• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK INC COOK SPECTRUM TURBO-JECT; LJS TURBO-JECT PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK INC COOK SPECTRUM TURBO-JECT; LJS TURBO-JECT PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER Back to Search Results
Model Number G34548
Medical Device Problem Codes Fitting Problem (2183); Detachment of Device or Device Component (2907)
Health Effect - Clinical Codes Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Device name: turbo-ject® double lumen minocycline/rifampin over-the-wire power-injectable picc occupation: lead rt.This report includes information known at this time.A follow-up report will be submitted should additional relevant information become available.
 
Event or Problem Description
It was reported that the orange hub of a turbo-ject® double lumen minocycline/rifampin over-the-wire power-injectable picc partially separated from the extension tubing.The line was used for infusion of "hl, carrier, valium, and valporate".Consequently, the device had to be removed and replaced.Additional information regarding the patient, device, and event has been requested but is currently unavailable.
 
Event or Problem Description
In additional information received on 10sep2021, it was reported that the patient did not experience any adverse effects due to this occurrence.
 
Additional Manufacturer Narrative
Blank fields on this form indicate the information is unknown or unavailable.Additional information: b5, h6 - annex e.This report includes information known at this time.A follow up report will be submitted should additional relevant information become available.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Additional Manufacturer Narrative
Investigation ¿ evaluation.It was reported by lurie children¿s hospital, usa that a turbo-ject® double lumen minocycline/rifampin over-the-wire power-injectable picc (rpn: upicds-4.0-ct-nt-abrm-1111; lot: 13768166) experienced a separation at the junction of the orange hub and the extension tube.The device was required by a four-year-old female for medication infusion.The picc was placed in the patient on (b)(6)2021.On (b)(6) 2021, separation between the orange hub and extension tube was noted.As a result, the patient reported to interventional radiology to remove and replaced the picc with an additional, unknown device.No other adverse effects were reported.Reviews of the complaint history, device history record (dhr), instructions for use (ifu), and quality control of the device were conducted during the investigation.The complaint device was not returned; therefore, no physical examinations could be performed.However, a photo was provided by the customer showing partial separation of the orange hub and extension tube.Additionally, a document-based investigation evaluation was performed.A review of the device master record (dmr) concluded that sufficient inspection activities are in place to identify this failure mode prior to distribution.A review of the design history file (dhf) showed that this device is both safe and effective for its intended use.A review of the device history record (dhr) for the reported complaint device lot (13768166) and the related subassembly lots revealed no non-conformances relevant to the failure mode.A database search found one additional complaint associated with this lot; this complaint was from the same facility and for the same reported failure.While there are additional complaints on this lot, there is currently no evidence of manufacturing deficiencies.Based on the available information, cook has concluded that there is no evidence suggesting nonconforming product exists either in house or in field.Cook also reviewed product labeling.The instructions for use (ifu) document t_upicabrmtt_rev1 [cook spectrum turbo-ject peripherally inserted central venous catheters with micropuncture peel-away introducers] is packaged with this device.The product ifu states the following in consideration of the reported failure mode: "intended use: the cook spectrum turbo-ject peripherally inserted central venous catheter (picc) sets are indicated for short- or long-term use for venous pressure monitoring, blood sampling, administration of drugs and fluids, and for use with power injectors for delivery of contrast in ct studies¿the maximum pressure limit setting for power injectors used with the spectrum turbo-ject picc may not exceed 325 psi and the flow rate may not exceed the maximum flow rate indicated, as shown on the following table.Warnings: ¿ the safe and effective use of spectrum turbo-ject picc lines with power injector pressures set above 325 psi has not been established.¿ do not power inject if maximum injection rate cannot be verified to meet limit printed on catheter hub or extension tube.¿ to safely use catheters with a power injector, the technician/health care professional must verify: ¿ prior to use that the maximum pressure limit is set at or below 325 psi and that the maximum flow rate is at or below that which is listed on the catheter.Precautions: ¿ if lumen flow is impeded, do not force injection or withdrawal of fluids.Catheter maintenance: if catheter is not to be used immediately, its lumen should be maintained by continuous saline or heparinized saline drip or locked with heparinized saline solution.How supplied: upon removal from package, inspect the product to ensure no damage has occurred." based on the available information, no product returned, and the results of the investigation, the root cause of this event is related to inadequate flexural strength in a previous hub design change.Appropriate measures have been taken to address this failure mode.A capa was previously opened to further investigate this failure mode.Per the quality engineering risk assessment no further action is required.The appropriate personnel have been notified.Cook will continue to monitor for similar complaints.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event or Problem Description
No additional information regarding the patient and/or event has been received since the previous medwatch report was sent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COOK SPECTRUM TURBO-JECT
Common Device Name
LJS TURBO-JECT PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER
Manufacturer (Section D)
COOK INC
750 daniels way
bloomington IN 47404
Manufacturer (Section G)
COOK INC
750 daniels way
bloomington IN 47404
Manufacturer Contact
jason crouch
750 daniels way
bloomington, IN 47404
8123392235
MDR Report Key12059837
Report Number1820334-2021-01594
Device Sequence Number20021492
Product Code LJS
UDI-Device Identifier00827002345485
UDI-Public(01)00827002345485(17)230104(10)13768166
Combination Product (Y/N)Y
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
K133634
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2021
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date (Section B) 04/18/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/04/2023
Device Model NumberG34548
Device Catalogue NumberUPICDS-4.0-CT-NT-ABRM-1111
Device Lot Number13768166
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Received by Manufacturer 06/15/2021
Supplement Date Received by Manufacturer09/10/2021
03/24/2022
Initial Report FDA Received Date06/24/2021
Supplement Report FDA Received Date09/14/2021
04/18/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/18/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age4 YR
Patient SexFemale
-
-